Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A letter from 124 patient groups urges the White House to make drugs more affordable—and spells out how it can do so.
During the COVID-19 crisis, some insurers are relaxing their refill rules and allowing 90-day supplies of meds to be prescribed.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Only one company will sell a version of the HIV prevention pill Truvada. When others go to market, prices will likely drop further.
Insurance companies can no longer implement harmful co-pay accumulator policies.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
Stop me if you’ve heard this one before.
The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.
Health coalition warns the federal government: People with chronic or serious conditions face growing costs at the pharmacy.
Among other issues: Out-of-pocket costs are increasingly passed on to consumers.
60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.
My fear of the dentist was setting me up for a future of teeth loss.
In summary: Bandage it or blow it up?
ViiV Healthcare, which makes several antiretroviral (ARV) drugs, is expanding programs to help HIV-positive people access the company’s...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.